menu
    • menu

    Company profile for Vivoryon Therapeutics

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Vivoryon Therapeutics has two decades of successful history in bringing pharmaceutical innovation to patients in need. Our programs are based on dedicated research, top-level discovery and determined development. We develop first-in-class medicines that target post-translational modifying enzymes. Our pipeline contains several product candidates across various stages of development, focused on Alzheimer’s Disease and oncolog...
    Vivoryon Therapeutics has two decades of successful history in bringing pharmaceutical innovation to patients in need. Our programs are based on dedicated research, top-level discovery and determined development. We develop first-in-class medicines that target post-translational modifying enzymes. Our pipeline contains several product candidates across various stages of development, focused on Alzheimer’s Disease and oncology.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Vivoryon TherapeuticsGermany Flag
    Country
    Country
    Germany
    Address
    Address
    Halle (Saale) Vivoryon Therapeutics AG Weinbergweg 22 06120 Halle (Saale)
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.vivoryon.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/probiodrug
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/VivoryonAG

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Vivoryon Reports 2025 Financials And Business Update
    Vivoryon Reports 2025 Financials And Business Update

    23 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/23/3279553/0/en/vivoryon-therapeutics-n-v-reports-full-year-2025-financial-results-and-provides-business-update.html

    GLOBENEWSWIRE
    23 Apr 2026
    Share Share
    Vivoryon Therapeutics N.V. To Share 2025 Financial Results
    Vivoryon Therapeutics N.V. To Share 2025 Financial Results

    15 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/15/3274111/0/en/Vivoryon-Therapeutics-N-V-to-Report-Full-Year-2025-Financial-Results-and-Business-Updates-on-April-23-2026.html

    GLOBENEWSWIRE
    15 Apr 2026
    Share Share
    Vivoryon Therapeutics N.V. To Attend Upcoming Investor Conference
    Vivoryon Therapeutics N.V. To Attend Upcoming Investor Conference

    09 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/09/3270633/0/en/Vivoryon-Therapeutics-N-V-to-Attend-Upcoming-Investor-Conference.html

    GLOBENEWSWIRE
    09 Apr 2026
    Share Share
    Vivoryon Updates Glutaminyl Cyclases As Key Targets In DKD
    Vivoryon Updates Glutaminyl Cyclases As Key Targets In DKD

    28 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/28/3264170/0/en/Vivoryon-Therapeutics-N-V-Provides-Update-on-Growing-Body-of-Evidence-Validating-Glutaminyl-Cyclases-as-Promising-Targets-in-DKD-at-World-Congress-of-Nephrology.html

    GLOBENEWSWIRE
    28 Mar 2026
    Share Share
    Vivoryon Therapeutics N.V. Presents At Upcoming Conferences
    Vivoryon Therapeutics N.V. Presents At Upcoming Conferences

    07 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/07/3214259/0/en/Vivoryon-Therapeutics-N-V-to-Attend-and-Present-in-Upcoming-Conferences.html

    GLOBENEWSWIRE
    07 Jan 2026
    Share Share
    Vivoryon Reports Q3 2025 Financials And Business Updates
    Vivoryon Reports Q3 2025 Financials And Business Updates

    04 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/04/3199483/0/en/Vivoryon-Therapeutics-N-V-Reports-Q3-2025-Financial-Results-and-Business-Updates.html

    GLOBENEWSWIRE
    04 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search